OverviewThe global NLP in healthcare and life sciences market is witnessing rapid expansion and is expected to grow at an ...
Likozam® will be reimbursed to patients starting June 12, 2026 Official reimbursement ends the “Early Access” clawbackThe ...
Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a broad population of people living with ...
Opinion
Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?
"One DEA Schedule I laboratory registration approved. FDA INDs granted. Orphan Drug Designation awarded. Yet the cultivation application remains unresolved as patients continue to wait. This is ...
Pesticides. Mycotoxins. Fraudulent Lab Reports. Forged Certificates of Analysis. This Is the State-Licensed Cannabis and Hemp Supply Chain the Courts and DEA Just Handed a Federal Registration Pathway ...
The global hemodynamic monitoring systems market is projected to witness steady growth during the forecast period, expanding ...
A leading alcohol‑reduction specialist credits advances in moderation therapies for a decline in the number of UK ...
The Poison Pill defends against no legitimate threat; 3D's acquisition of additional shares is not aimed at seizing ...
Camzyos has the potential to be the first pharmacological therapy for the treatment of oHCM in adolescents, addressing a high unmet need for this populationApplication based on positive results of ...
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to ...
Nature-Cide X2 Plus Selected as Preferred All-Natural SolutionAs Customer Demand Trends Toward Natural Pest Control Solutions, Mosquito Authority / Pest Authority Launches Company-Wide Initiative to ...
UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph® neuromuscular monitoring system has received an additional FDA Class II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results